ICUI stock: buy or sell?
August 22nd, 2019
ICU Medical, Inc. develops, manufactures, and sells medical devices used in infusion therapy, critical care, and oncology applications worldwide.
Should I buy ICUI stock?Trading stocks requires experience and discipline, and your buying and selling decisions must come following a methodology. That's why is so important to define your own trading strategy that matches with your character as inversor. At Stocks2.com, we like to use very simple but trusted and powerful trend following trading strategies. Simple things usually work the best.
None of our preferred buy setups matches with ICU Medical stock situation right now, hence this is not a suitable entry point.
|New all-time high||No|
|New 52 week high||No|
|Price crossing up 200d MA||No|
|100d MA crossing up 200d MA||No|
Is ICU Medical stock a buy?
Everyday, hundreds of stock ratings are published by financial analysts to indicate a particular stock's attractiveness.At Stocks2.com, we collected 3 ratings published for ICUI stock in the last month.
|Date||Analyst / Broker||Previous rating||Current rating|
ICUI stock analysis
ICU Medical closed yesterday at $166.41 and gained a slightly good 0.89%.
ICU Medical shares gained 0.89% to $166.41 yesterday. Since August 8th when ICUI stock price broke down the SMA200d line, it slid $-79.26 per share (-32.26%). Since SMA50d and SMA100d crossed up on July 12th, ICUI price slid a -32.51%.
ICU Medical stayed stable a tight 0.25% this week. Early August ICUI collapsed a chilling -53.36% in just one week.
Since early August, when ICUI stock price broke down the 40-weeks moving avarage line, it slid $-89.54 per share (-34.98%). Trading stocks that are under the 40-weeks (that is, 200-days) moving average line is not recommended by many experts, as it indicates that the stock has not enough institutional support.
ICUI stock price history
ICUI stock went public on March 31st, 1992 with a price of $5.331. Since then, ICUI stock surged a 3,022.10%, with an average of 111.90% per year. If you had invested right after ICUI's IPO a $1,000 in ICUI stock in 1992, it would worth $30,221.00 today.
1: Adjusted price after possible price splits or reverse-splits.
ICUI stock historical price chart
ICUI stock reached 52-week highs on September at $312.45, and all-time highs 2018-08-10 with a price of 321.7.
ICUI stock price target is $300.00Nobody can reliably foresee how stock prices may evolve in the future. However, many stock price predictions are published every day by banks, financial institutions and independent analysts. We do not recommend to follow these stock price predictions without a critical thinking from your side, as their accuracy is usually low. We found 2 price predictions for ICUI stock published in the last month:
|Date||Analyst / Broker||Action||Previous target||Current target||Diff|
|2019-3-1||Raymond James||Lowers Target||$315.00||$300.00||-4.8%|
Financials and fundamental analysis
Earnings date and Earnings per ShareICU Medical presented more than good results for 2018-Q4 on February. ICU Medical soared Earnings per Share (EPS) by 14.10%, beating experts estimates of $1.56. ICU Medical posted $1.78.
|Quarter||Reporting date||Estimated EPS||Actual EPS||Surprise|
Annual financial resultsCompared to 2017, last anual revenues report draw a more than good increase of 8.31% to $1,400.04 million dollars. However, its income margin (compared to sales) declined to 2.06%, that is $28.79 million.
|2013||$314 M||-||$40 M12.9%||-|
|2014||$309 M||-1.42%||$26 M8.5%||-34.85%|
|2015||$342 M||10.48%||$45 M13.2%||70.82%|
|2016||$379 M||11.04%||$63 M16.6%||40.23%|
|2017||$1,293 M||240.72%||$69 M5.3%||8.81%|
|2018||$1,400 M||8.31%||$29 M2.1%||-58.05%|
Quarterly financial resultsICU Medical posted $340.38 M in revenues for 2018-Q4, a 4.04% improvement compared to previous quarter. Reported quarter earnings marked $-7.36 million with a profit margin of -2.16%. Profit margin depreciated a -2.23% compared to previous quarter when profit margin was 0.07%. When comparing revenues to same quarter last year, ICU Medical sales marked a terrifying correction and dropped a -8.04%.
|2017-Q1||$248 M||-||$56 M22.5%||-|
|2017-Q2||$332 M||33.81%||$-37 M-11.2%||-166.34%|
|2017-Q3||$343 M||3.54%||$0 M0.0%||-100.37%|
|2017-Q4||$370 M||7.83%||$50 M13.4%||36,447.79%|
|2018-Q1||$372 M||0.52%||$5 M1.3%||-90.19%|
|2018-Q2||$360 M||-3.11%||$31 M8.6%||537.01%|
|2018-Q3||$327 M||-9.24%||$0 M0.1%||-99.29%|
|2018-Q4||$340 M||4.04%||$-7 M-2.2%||-3,458.45%|
ICU Medical ownershipWhen you are planning to buy shares of a company, it's always worth to review its ownership structure.
Management staff in all public traded companies that hold equity is required to report every transaction to the SEC. For ICU Medical, 7.13% of all outstanding shares are owned by its staff.
Bearish positions for ICUI stock account 0.00%, no big difference from last month.
For a better context understanding, the next table shows ownership data compared to other related companies:
|Market cap||$3.4 B||$696.4 M||$44.5 B||$68.8 B||$45.1 B|
|Total shares||20.6 M||37.3 M||510.2 M||269.7 M||208.1 M|
|Float shares||19.2 M||36.8 M||509.5 M||269.1 M||206.6 M|
|- Institutional holdings (%)||93.5%||102.5%||88.2%||87.5%||0.0%|
|- Insider holdings (%)||7.1%||2.5%||0.1%||0.3%||3.9%|
|Shares in short selling||0.0%||0.0%||0.0%||0.0%||0.0%|
|Thursday, August 22nd, 2019|
|Day range||$163.96 - $167.98|
|Average true range||$11.46|
|50d mov avg||$230.70|
|100d mov avg||$229.53|
|200d mov avg||$233.51|
ICU Medical performanceTo better understand ICU Medical performance you must becnhmark its gains with other related stocks in same sector or industry. For ICU Medical, the benchmark is made against AngioDynamics, Baxter International, Becton, Dickinson and, Edwards Lifesciences, Merit Medical Systems, Insulet and Teleflex.
|MMSIMerit Medical Sys...||-34.33%||-41.88%||-39.91%|